Resistant Hypertension With New Hypokalemia in a 46-Year-Old Man
A 46-year-old man returns for a third visit with home BP averaging 152/96 mmHg over the past month despite adherence to amlodipine 10 mg and losartan 100 mg daily; he has taken losartan for two years. He reports no chest pain, headache, or flushing. Last week's labs: sodium 141 mmol/L, potassium 3.3 mmol/L (reference 3.5-5.0), bicarbonate 29 mmol/L, creatinine 1.0 mg/dL, glucose 96 mg/dL, TSH normal. He takes no diuretics, NSAIDs, or licorice and denies vomiting or diarrhea. Two years ago his potassium was 3.9 mmol/L. He is not obese, does not snore, and has no family history of early hypertension. He asks whether he simply needs a stronger pill.
1. Interpret the laboratory pattern and rank the differential for his resistant hypertension.
Read the worked answer
The pattern is the clue: hypokalemia plus a bicarbonate of 29 mmol/L (metabolic alkalosis) plus hypertension that persists on two agents is the classic biochemical signature of mineralocorticoid excess. Hypokalemia was absent two years ago and is now present, which suggests an evolving process rather than a lifelong trait.
Differential, ranked:
- Primary aldosteronism - the most common secondary cause of resistant hypertension and far more prevalent than traditionally taught; the hypokalemia and alkalosis fit, though most cases are normokalemic
- Medication effect - he denies diuretics, but confirm by reviewing the actual bottle and any over-the-counter products, including licorice-containing supplements and chewing tobacco
- Renal artery stenosis - less likely without an abdominal bruit, flash pulmonary edema, or creatinine rise after starting an ACE inhibitor or ARB
- Obstructive sleep apnea and thyroid disease - both are plausible contributors in general, but his body habitus, absence of snoring, and normal TSH make them low yield here
- Rare causes - Cushing syndrome, pheochromocytoma, congenital adrenal hyperplasia; none has supporting features yet
Reasoning: the exam is testing whether you escalate antihypertensives reflexively or stop and ask why a 46-year-old is resistant with a new electrolyte abnormality.
2. What must be done before and around ordering an aldosterone-renin ratio, and what interferes with it?
Read the worked answer
Correct the confounders first, or the test will mislead you.
- Replete potassium to at least 3.5 mmol/L (many would target 4.0), since hypokalemia suppresses aldosterone and can produce a false-negative ratio
- Do not restrict salt; liberalize sodium so the renin-aldosterone axis is not stimulated
- Medications: losartan lowers aldosterone and raises renin, which can mask the diagnosis. Amlodipine is relatively neutral. Where blood pressure allows, substitute verapamil, hydralazine, or doxazosin for the interfering agents for roughly two weeks before testing; if substitution is unsafe, test on the current regimen and interpret cautiously
- Document potassium, sodium, and any diuretic, ACE inhibitor, ARB, beta-blocker, NSAID, or mineralocorticoid receptor antagonist use at the time of the draw
Then order a paired morning plasma aldosterone concentration and plasma renin activity (or direct renin), seated, ideally before 10 a.m. An elevated aldosterone with suppressed renin - an aldosterone-to-renin ratio in the range of 20-30 with aldosterone above roughly 15 ng/dL - is a positive screen, not a diagnosis.
Reasoning: the exam frequently tests the sequence, not the ratio cutoff. Testing without correcting hypokalemia or with an ARB on board is the most common way to miss primary aldosteronism.
3. The ratio returns elevated with suppressed renin. What are the next steps, and what determines surgery versus medication?
Read the worked answer
Step 1 - confirm the screen. A positive ratio requires confirmatory testing, typically oral sodium loading or a captopril challenge (choose based on safety; sodium loading is avoided with uncontrolled hypertension or severe hypokalemia). Confirmation is not needed in every case, but in a patient with hypokalemia and resistant hypertension it is still standard to document autonomous secretion.
Step 2 - lateralize. Order adrenal CT to look for an adenoma, but remember that CT alone cannot exclude bilateral hyperplasia and cannot confirm that a nodule is the source. If the patient is a surgical candidate and wants surgery, adrenal vein sampling is required to distinguish unilateral from bilateral disease - this is the step that is most often skipped.
Step 3 - treat.
- Unilateral disease in a surgical candidate: laparoscopic adrenalectomy, with repeat potassium and blood pressure assessment afterward
- Bilateral hyperplasia, or a patient who is not a surgical candidate: a mineralocorticoid receptor antagonist (spironolactone, or eplerenone if gynecomastia is a concern), titrated to potassium and renin
- Either way, expect to reduce other antihypertensives and to recheck potassium within one to two weeks of any change
Reasoning: the trap is treating a positive ratio with a pill and never determining whether this is a curable unilateral adenoma.